Literature DB >> 22332461

Magic bullets and moving targets: antibiotic resistance and experimental chemotherapy, 1900-1940.

Christoph Gradmann1.   

Abstract

It was in the 1940s that antibiotic resistance arose as an object of study for clinical medicine. Somewhat earlier it had become an important analytical tool for bacterial geneticists. However, the concept of antibiotic resistance as an induced and inheritable trait of microbial species was introduced a generation earlier in the years preceding the First World War. The paper reconstructs the concept that was put forward by the German immunologist Paul Ehrlich in 1907. He came across the phenomenon when trying to develop chemotherapies for trypanosomiasis, the best known of which is African sleeping sickness. However, resistance was studied by him for other than therapy-related purposes. It provided a productive laboratory model for the study of cell functions. Induced resistance to chemicals facilitated the development of ideas on the relation of a parasite's cellular metabolism and of drug action, i.e. by providing a negative proof for the existence of chemoreceptors on the surfaces of parasite cells. This approach does also serve to explain why British and German researchers continued to study the phenomenon of induced resistance in microbes for decades -despite it being absent from clinical medicine. After all, there existed very few chemotherapies of infectious diseases prior to the arrival of the sulfa drugs. Moreover, resistance to such medicines was rarely observed. However, being part and parcel of Ehrlich's theories, his views on resistance were also criticised together with these. It was in particular Henry Dale who would challenge Ehrlich's views of resistance being an inheritable and stable trait of microbes. Instead he insisted that understanding this "wholly mysterious phenomenon" required taking into account some host interaction. Induced resistance, which had come into being as a chance discovery on the chemotherapy of sleeping sickness, thus became one of the more important laboratory models of twentieth-century immunological research. Its early history is largely discontinuous with later work, and antimicrobial resistance as it evolved from 1900 to 1940 followed other trajectories than those which became relevant after 1940.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22332461     DOI: 10.4321/s0211-95362011000200003

Source DB:  PubMed          Journal:  Dynamis        ISSN: 0211-9536            Impact factor:   0.429


  8 in total

1.  The Bacterial Cell Wall in the Antibiotic Era: An Ontology in Transit Between Morphology and Metabolism, 1940s-1960s.

Authors:  María Jesús Santesmases
Journal:  J Hist Biol       Date:  2016-02       Impact factor: 1.326

2.  Identification of Specific and Nonspecific Inhibitors of Bacillus anthracis Type III Pantothenate Kinase (PanK).

Authors:  Justin A Shapiro; John J Varga; Derek Parsonage; William Walton; Matthew R Redinbo; Larry J Ross; E Lucile White; Robert Bostwick; William M Wuest; Al Claiborne; Joanna B Goldberg
Journal:  ChemMedChem       Date:  2018-12-03       Impact factor: 3.466

Review 3.  Phage therapy against Enterococcus faecalis in dental root canals.

Authors:  Leron Khalifa; Mor Shlezinger; Shaul Beyth; Yael Houri-Haddad; Shunit Coppenhagen-Glazer; Nurit Beyth; Ronen Hazan
Journal:  J Oral Microbiol       Date:  2016-09-16       Impact factor: 5.474

Review 4.  Selective toxicity of antibacterial agents-still a valid concept or do we miss chances and ignore risks?

Authors:  Axel Dalhoff
Journal:  Infection       Date:  2020-12-23       Impact factor: 7.455

5.  Wars and sweets: microbes, medicines and other moderns in and beyond the(ir) antibiotic era.

Authors:  Coll Hutchison
Journal:  Med Humanit       Date:  2022-08-10

Review 6.  Targeted Drug Delivery - From Magic Bullet to Nanomedicine: Principles, Challenges, and Future Perspectives.

Authors:  Ashagrachew Tewabe; Atlaw Abate; Manaye Tamrie; Abyou Seyfu; Ebrahim Abdela Siraj
Journal:  J Multidiscip Healthc       Date:  2021-07-05

7.  Double Standards in Global Health: Medicine, Human Rights Law and Multidrug-Resistant TB Treatment Policy.

Authors:  Thomas Nicholson; Catherine Admay; Aaron Shakow; Salmaan Keshavjee
Journal:  Health Hum Rights       Date:  2016-06

Review 8.  Setting the standard: multidisciplinary hallmarks for structural, equitable and tracked antibiotic policy.

Authors:  Claas Kirchhelle; Paul Atkinson; Alex Broom; Komatra Chuengsatiansup; Jorge Pinto Ferreira; Nicolas Fortané; Isabel Frost; Christoph Gradmann; Stephen Hinchliffe; Steven J Hoffman; Javier Lezaun; Susan Nayiga; Kevin Outterson; Scott H Podolsky; Stephanie Raymond; Adam P Roberts; Andrew C Singer; Anthony D So; Luechai Sringernyuang; Elizabeth Tayler; Susan Rogers Van Katwyk; Clare I R Chandler
Journal:  BMJ Glob Health       Date:  2020-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.